[
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-1",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#definitiongeneral130033",
    "clean_content": "Definition / general\n\n* 1 of 2 types of autoimmune pancreatitis, characterized by clinical evidence of jaundice, with or without formation of a pancreatic mass on radiographic imaging, with excellent clinical response to steroid treatment* Unlike type 1 autoimmune pancreatitis, type 2 is IgG4 negative and does not show extra\n    pancreatic organ involvement and is not associated with increased IgG4 in serum or IgG4 positive\n    plasma cells* Diagnosis requires histologic confirmation of granulocytic epithelial lesions ([Pancreas 2011;40(3):352](21412117), [Am J Surg Pathol 2003;27:1119](12883244))"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-2",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#essentialfeatures130034",
    "clean_content": "Essential features\n\n* Characterized by clinically nonspecific signs and symptoms, radiographic evidence of pancreas enlargement, histologic evidence of destructive duct centric inflammation with granulocytic epithelial lesions, with an excellent response to treatment with steroids"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-3",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#terminology130035",
    "clean_content": "Terminology\n\n* Autoimmune pancreatitis type 2, idiopathic duct centric pancreatitis, autoimmune pancreatitis with granulocyte epithelial lesions, nonalcoholic duct destructive pancreatitis"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-4",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#epidemiology130036",
    "clean_content": "Epidemiology\n\n* Incidence largely unknown; requirement of tissue for definitive histologic diagnosis limits estimates\n  of true incidence; thought to be less common than type 1 autoimmune pancreatitis (< 1 per\n  100,000) ([Int J Rheumatol 2012;2012:358371](22899936))* Age: mean 40 - 44 years ([Gut 2013;62:1771](23232048), [Pancreas 2011;40:809](21747310))* Sex: M = F"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-5",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#sites130037",
    "clean_content": "Sites\n\n* Pancreas* No significant extra pancreatic involvement"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-6",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#pathophysiology130038",
    "clean_content": "Pathophysiology\n\n* Largely unknown"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-7",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#etiology130039",
    "clean_content": "Etiology\n\n* Largely unknown"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-8",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#clinicalfeatures130040",
    "clean_content": "Clinical features\n\n* Numerous, nonspecific signs and symptoms* Jaundice, weight loss, abdominal pain, diffuse enlargement or mass forming lesion on imaging* No biochemical evidence of pancreatitis, absent serum IgG4, no extra pancreatic organ involvement ([Pancreas 2011;40:809](21747310))* An association with inflammatory bowel disease, especially ulcerative colitis, is observed in up to 15% of cases ([Gastroenterology 2015;149:39](25770706))"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-9",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Diagnostic criteria",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#diagnosticcriteria130041",
    "clean_content": "Diagnostic criteria\n\n* Histologic examination of tissue is critical for diagnosis per International Consensus Diagnostic Criteria 2011 ([Pancreas 2011;40(3):352](21412117))* Categorization as \"definitive\" or \"probable\" based on histologic criteria:\n    + Level 1\n      - Granulocytic infiltration of duct wall [aka granulocytic epithelial lesion(s)] with or without granulocytic acinar inflammation- Absent or scant IgG4 positive cells (0 - 10 cells/high powered fields)+ Level 2\n        - Granulocytic and lymphoplasmacytic acinar infiltrate- Absent or scant IgG4 positive cells (0 - 10 cells/high powered fields)* Definitive type 2 autoimmune pancreatitis:\n      + Level 1 histologic findings with supportive findings on imaging **or** level 2 histologic findings, supportive findings on imaging, clinical inflammatory bowel disease and response to steroid treatment* Probable type 2 autoimmune pancreatitis:\n        + Level 2 histologic findings, supportive findings on imaging, variable inflammatory bowel disease and response to steroid treatment"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-10",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Laboratory",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#laboratory130042",
    "clean_content": "Laboratory\n\n* No serum biomarkers have been elucidated ([Pancreas 2011;40:809](21747310))* No biochemical evidence of pancreatitis (normal serum amylase, lipase)"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-11",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#radiologydescription130043",
    "clean_content": "Radiology description\n\n* No specific radiologic features to distinguish type 2 from type 1* Contrast enhanced ultrasound ([Endosc Ultrasound 2018;7:196](28836516)):\n    + Noninvasive imaging study; dynamic contrast enhancement improved discrimination between autoimmune pancreatitis and pancreatic ductal adenocarcinoma+ Shows iso or hyperenhancement during the arterial and phases* CT ([AJR Am J Roentgenol 2015;205:2](26102377)):\n      + Important imaging modality for differentiation from pancreatic cancer+ Diffuse parenchymal involvement, sausage shaped+ Delayed enhancement studies+ Rim-like enhancement* Magnetic resonance ([Pancreas 2018;47:1115](30141780), [Radiology 2011;260:428](21613442))\n        + T1 weighted: hypointense+ T2: predominantly hyperintense+ Dynamic study shows the effect of fibrosis widening the extracellular and extravascular spaces, resulting in hypointensity during pancreatic phase and contrast retention / hyperintensity during the delayed phase* Magnetic resonance cholangiopancreatography ([Pancreas 2018;47:1115](30141780))\n          + Stenosis of the main pancreatic duct, however with less upstream dilatation than seen in type 1 autoimmune pancreatitis+ Rare / absent common bile duct stenosis and rare / absent stenosis of intrahepatic bile ducts, consistent with no extra pancreatic organ involvement in type 2 autoimmune pancreatitis compared to type 1 autoimmune pancreatitis"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-12",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Radiology images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#radiologyimages130044",
    "clean_content": "Radiology images\n\nImages hosted on other servers:  \n\n[![Missing Image](https://www.pathologyoutlines.com/thumb/pancreasaiptype2radio1.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232013/figure/g001/)\n\nDiffuse pancreas enlargement"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-13",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#prognosticfactors130045",
    "clean_content": "Prognostic factors\n\n* Excellent prognosis (up to 99% remission) with steroid treatment* Low risk of recurrence (10 - 15%) ([Gut 2013;62:1771](23232048))"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-14",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#casereports130046",
    "clean_content": "Case reports\n\n* 9 year old girl with intrahepatic and extrahepatic biliary ductal dilatation ([Clin J Gastroenterol 2015;8:421](26590828))* 20 year old man with Crohn's disease ([Intern Med. 2018 Oct 15;57(20):2957](29526939))* 64 year old man with inflammatory bowel disease and dilated common bile duct ([J Investig Med High Impact Case Rep 2017;5:2324709617734245](29051892))"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-15",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#treatment130047",
    "clean_content": "Treatment\n\n* Steroids, up to 99% response ([Gastrointest Endosc Clin N Am 2018;28:493](30241640))* Immune modulation (rituximab, methotrexate)* Surgical resection of pancreas in rare cases unresponsive to medical management"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-16",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#microscopichistologicdescription130048",
    "clean_content": "Microscopic (histologic) description\n\n* Confined to pancreas* Key histologic features:\n    + Lymphoplasmacytic inflammation, predominantly periductal, although acini are also involved+ Epithelium of medium and small sized duct walls infiltrated by neutrophils [(granulocytic\n        epithelial lesion(s)] with or without granulocytic acinar inflammation\n        - Often causes destruction of the pancreatic duct epithelium* Lobular fibrosis (but not storiform) and obliterative phlebitis, however less prominent than in type 1 autoimmune pancreatitis* Absent or scant IgG4 positive cells (plasma cells) (0 - 10 cells / high powered fields) ([Gastroenterology 2015;149:39](25770706))"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-17",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#microscopichistologicimages130049",
    "clean_content": "Microscopic (histologic) images\n\n*Contributed by David J. Escobar, M.D., Ph.D.*  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasaiptype2Escobar01new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasaiptype2Escobar01new.jpg)\n \n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasaiptype2Escobar02new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasaiptype2Escobar02new.jpg)\n\nGranulocyte epithelial lesion\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasaiptype2Escobar03new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasaiptype2Escobar03new.jpg)\n\nIgG4-"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-18",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#positivestains130050",
    "clean_content": "Positive stains\n\n* IHC not necessary for diagnosis* One study has suggested a role for evaluating **IL8** expression in ductal epithelium (85% versus 0% in type 1 autoimmune pancreatitis) and infiltrating neutrophils (100% versus 0% in type 1 autoimmune pancreatitis) ([Am J Surg Pathol 2017;41:1129](28614208))"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-19",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#negativestains130051",
    "clean_content": "Negative stains\n\n* Scant or absent [IgG4](https://www.pathologyoutlines.com/topic/stainsigg4.html)"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-20",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#differentialdiagnosis130052",
    "clean_content": "Differential diagnosis\n\n* [Pancreatic ductal adenocarcinoma](https://www.pathologyoutlines.com/topic/pancreasductal.html)\n  + Most important entity to exclude when considering autoimmune pancreatitis+ May present as jaundice, with infiltrative mass on radiographic imaging, variable serum [IgG4](https://www.pathologyoutlines.com/topic/stainsigg4.html) levels, variable elevated serum [CA 19-9](https://www.pathologyoutlines.com/topic/stainsca19-9.html) levels+ Radiographic findings may be similar with contrast enhancement* [Autoimmune pancreatitis type 1](https://www.pathologyoutlines.com/topic/pancreasaiptype1.html)\n    + Associated with an older age group+ Serum [IgG4](https://www.pathologyoutlines.com/topic/stainsigg4.html) levels may be elevated+ Histology shows dense lymphoplasmacytic infiltrate, storiform fibrosis and obliterative phlebitis+ [IgG4](https://www.pathologyoutlines.com/topic/stainsigg4.html) positive plasma cells may be present, considered IgG4 related if IgG4/IgG ratio > 40% ([Virchows Arch 2018;472:545](29196804))* [Alcoholic / gallstone pancreatitis](https://www.pathologyoutlines.com/topic/pancreasacute.html)\n      + Acute pancreatitis that occurs in any age group+ Elevated **amylase** and **lipase**+ Histology is not needed for diagnosis, shows acute interstitial inflammation with spotty peripancreatic fat necrosis (mild cases) or large areas of saponification, hemorrhage and spotty widened viable acinar lumens (severe cases)* [Chronic pancreatitis](https://www.pathologyoutlines.com/topic/pancreaschronic.html)\n        + Progressive inflammation and fibrosis of the pancreas, resulting in waxing and waning nausea, weight loss, fat malabsorption (steatorrhea) and diabetes+ May have elevated serum [CA 19-9](https://www.pathologyoutlines.com/topic/stainsca19-9.html)+ Histology reveals atrophy of acini and ducts with preservation of pancreatic lobular architecture, variable amount of fibrosis centered around ducts and between lobules and mild chronic inflammatory cell infiltrate ([Mod Pathol 2007;20:S113](17486047))"
  },
  {
    "id": "autoimmune-pancreatitis-type-2_27358_1750166972.txt-21",
    "source_document": "autoimmune-pancreatitis-type-2_27358_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/pancreasaiptype2.html#additionalreferences130053",
    "clean_content": "Additional references\n\n* [Pancreatology 2010;10:664](21242705), [Virchows Arch 2004;445:552](15517359), [Gastroenterol Clin North Am 2016;45:29](26895679)"
  }
]